Literature DB >> 22881133

Training lay counsellors to provide psychosocial support to ART users: successes and failures.

Ashraf Kagee1.   

Abstract

This study reports on a pilot project to train eight patient advocates (PAs) who provided psychosocial support to users of antiretroviral therapy (ART) in basic counselling skills. PAs received 18 hours of training over the course of 3 months. A cadre of raters evaluated the PAs after the training using the Counsellor Rating Form and a Counsellor Evaluation Form. Counsellor activities that were rated as approaching acceptability were: reflection of content, encouraging, summarising, gathering data, exploring alternatives, giving directives and terminating the session. Counselling activities rated as requiring further training were reflection of feeling, interpretation, exploring logical consequences, confrontation, identifying positive assets and challenging. These results are discussed in the context of creating and sustaining a health-enabling community for ART users.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22881133     DOI: 10.1080/09540121.2012.712672

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  3 in total

1.  Shortcomings of adherence counselling provided to caregivers of children receiving antiretroviral therapy in rural South Africa.

Authors:  Bronwyne Coetzee; Ashraf Kagee; Ruth Bland
Journal:  AIDS Care       Date:  2016-03

2.  Development of a Blended Learning Approach to Delivering HIV-Assisted Contact Tracing in Malawi: Applied Theory and Formative Research.

Authors:  Nora Ellen Rosenberg; Tapiwa A Tembo; Katherine R Simon; Katie Mollan; Sarah E Rutstein; Victor Mwapasa; Steven Masiano; Hanna E Huffstetler; Vivian Go; Maria H Kim
Journal:  JMIR Form Res       Date:  2022-04-19

3.  Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus.

Authors:  Connie T Kekwaletswe; Neo K Morojele
Journal:  Patient Prefer Adherence       Date:  2014-03-31       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.